<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01217099</url>
  </required_header>
  <id_info>
    <org_study_id>ChiCTR-TRC2</org_study_id>
    <nct_id>NCT01217099</nct_id>
  </id_info>
  <brief_title>Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children</brief_title>
  <acronym>MPP</acronym>
  <official_title>A Prospective, Open-label Trial of Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is planned to investigate whether small doses of methylprednisolone
      pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy
      for refractory mycoplasma pneumoniae pneumonia(MPP) .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Corticosteroid has been used in adulthood refractory MPP with satisfactory efficacy. But
      there were few studies about the use of corticosteroid in children with refractory MPP. Lee
      KY et al indicated oral prednisolone of 1 mg/kg/ day for 1 week be useful for children with
      severe MPP. Akihiro T et al demonstrated that intravenously administered methylprednisolone
      at a dose of 30 mg/kg once daily for 3 consecutive days had an efficacious treatment for
      children with refractory MPP.But the methods of corticosteroid use, such as the dosage,
      administration route, duration of treatment have not been well understood. So in this study,
      we planned to investigate whether small doses of methylprednisolone pulse macrolide therapy
      can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory
      mycoplasma pneumoniae pneumonia in a prospective, open-label fashion.

      PMID: 11096025 PMID: 18033831 PMID: 10434547 PMID: 16437541 PMID: 18656264
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    terminated
  </why_stopped>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy of methylprednisolone pulse macrolide therapy for children with refractory MPP.</measure>
    <time_frame>3-year</time_frame>
    <description>compare the temperature , infiltration absorption,atelectasis resolution, pleural effusion disappearance,serum levels of ferritin and LDH between methylprednisolone pulse macrolide therapy group and macrolide therapy group .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety of methylprednisolone pulse macrolide therapy for children with refractory MPP.</measure>
    <time_frame>3-year</time_frame>
    <description>observe the further complications of infection between methylprednisolone pulse macrolide therapy group and macrolide therapy group .</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Refractory Mycoplasma Pneumoniae Pneumonia</condition>
  <arm_group>
    <arm_group_label>methylprednisolone</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>methylprednisolone pulse azithromycin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>azithromycin</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>azithromycin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylprednisolone</intervention_name>
    <description>treatment patients were iv methylprednisolone pulse azithromycin for 5 days.</description>
    <arm_group_label>methylprednisolone</arm_group_label>
    <other_name>treatment group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>azithromycin</intervention_name>
    <description>control patients were iv azithromycin for 5 days.</description>
    <arm_group_label>azithromycin</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mycoplasma pneumoniae pneumonia

          -  prolonged fever and deterioration of radiological findings despite macrolides
             treatment for 7 days or more.

        Exclusion Criteria:

          -  chronic cardiac and pulmonary disease

          -  immunodeficiency

          -  requiring mechanical ventilation

          -  with other pathogens detected during pneumonia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zhengxiu luo, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chongqing Medical University</affiliation>
  </overall_official>
  <link>
    <url>http://www.clinicaltrials.gov</url>
  </link>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2010</study_first_submitted>
  <study_first_submitted_qc>October 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2010</study_first_posted>
  <last_update_submitted>October 7, 2010</last_update_submitted>
  <last_update_submitted_qc>October 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>zhengxiu luo</name_title>
    <organization>Children's Hospital of Chongqing Medical University</organization>
  </responsible_party>
  <keyword>refractory mycoplasma pneumoniae pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pleuropneumonia</mesh_term>
    <mesh_term>Mycoplasma Infections</mesh_term>
    <mesh_term>Pneumonia, Mycoplasma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

